Heparanase expression correlates with poor survival in metastatic ovarian carcinoma
- 28 February 2007
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 104 (2), 311-319
- https://doi.org/10.1016/j.ygyno.2006.08.045
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- An ELISA method for the detection and quantification of human heparanaseBiochemical and Biophysical Research Communications, 2006
- Angiogenic Molecule Expression is Downregulated in Effusions from Breast Cancer PatientsBreast Cancer Research and Treatment, 2005
- Detection of peritoneal micrometastasis by reverse transcriptase‐polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samplesJournal of Surgical Oncology, 2005
- Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinomaLaboratory Investigation, 2005
- Heparanase Uptake Is Mediated by Cell Membrane Heparan Sulfate ProteoglycansPublished by Elsevier BV ,2004
- Processing and activation of latent heparanase occurs in lysosomesJournal of Cell Science, 2004
- Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinomaJournal of Surgical Oncology, 2002
- Loss of Syndecan‐1 and Increased Expression of Heparanase in Invasive Esophageal CarcinomasJapanese Journal of Cancer Research, 2001
- Heparanase as mediator of angiogenesis: mode of actionThe FASEB Journal, 2001
- Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimensInternational Journal of Cancer, 1990